v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues        
Services $ 0 $ 88,896 $ 58,949 $ 366,150
Product 1,613,876 538,381 2,938,660 914,200
Total Revenues 1,613,876 627,277 2,997,609 1,280,350
Operating Expenses        
Research and development 1,989,609 2,285,907 6,642,516 7,613,228
General and administrative 2,381,674 2,483,793 7,239,957 7,667,909
Sales and marketing 576,730 958,567 1,976,944 2,919,400
Total Operating Expenses 4,948,013 5,728,267 15,859,417 18,200,537
Operating Loss (3,334,137) (5,100,990) (12,861,808) (16,920,187)
Other Income (Expenses)        
Grant income 28,685 232,184 103,302 429,411
Gain on disposal of fixed assets 260 0 2,361 330
Interest income 0 160 179 478
Interest expense (142,816) (143,800) (1,009,046) (363,825)
Amortization of debt discount (324,480) (729,630) (1,179,682) (1,054,935)
Gain (loss) on change in fair value of derivative liability 198,900 304,443 (1,078,858) 723,124
Gain (loss) on change in fair value of warrant liability 6,400 27,842 20,978 (14,884)
Loss on extinguishment of debt (240,201) 0 (1,823,635) 0
Total Other Expenses (473,252) (308,801) (4,964,401) (280,301)
Net Loss (3,807,389) (5,409,791) (17,826,209) (17,200,488)
Net Loss Attributable to Non-Controlling Interest 7,798 31,433 35,797 114,293
Net Loss Attributable to VolitionRx Limited Stockholders (3,799,591) (5,378,358) (17,790,412) (17,086,195)
Other Comprehensive Income (Loss)        
Foreign currency translation adjustments 12,563 22,348 219,183 (807,577)
Net Comprehensive Loss (3,794,826) (5,387,443) (17,607,026) (18,008,065)
Net Loss Attributable to VolitionRx Limited Stockholders (3,799,591) (5,378,358) (17,790,412) (17,086,195)
Deemed dividend - down round provision in warrants (103,200) 0 (563,300) 0
Net Loss Attributable to Common Stockholders $ (3,902,791) $ (5,378,358) $ (18,353,712) $ (17,086,195)
Net Loss Per Share - Basic and Diluted Attributable to VolitionRx Limited $ (0.21) $ (0.99) $ (1.57) $ (3.35)
Weighted Average Shares Outstanding - Basic and Diluted 18,901,452 5,410,653 11,660,813 5,105,764

Source